URGN
UroGen Pharma Ltd
41.40$
+0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | 172.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | 6.6 | 12.4 | 31.7 | 46.2 | 87.5 | 522.0 | 354.2 | 478.3 | 652.6 | 576.8 | 39,260.1 | 20,923.1 | 1,526.2 | 111.1 | 33.8 | 22.5 | 10.7 | 9.4 | 4.4 | 3.6 | 3.2 | 3.0 | 3.2 | 3.2 | 3.4 | 5.9 | 6.6 | 5.9 | 7.3 | 6.1 | 5.6 | 5.7 | 6.9 | 10.0 | 10.5 | 6.4 | 9.8 | |
| – | – | – | 2.2 | 5.4 | 7.4 | 6.1 | 6.9 | 7.3 | 7.8 | 3.0 | 3.3 | 2.4 | 3.9 | 2.5 | 4.0 | 3.5 | 4.1 | 5.7 | 6.1 | 11.9 | 25.3 | – | – | – | – | – | – | – | – | – | 20.4 | 21.5 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 315.1 | 574.7 | 501.5 | – | 19,543.3 | 1,432.5 | 105.0 | – | 20.5 | 8.7 | 8.1 | 3.6 | 3.0 | 3.1 | 3.7 | 3.9 | 4.1 | 4.5 | 5.6 | 6.6 | 5.5 | 5.9 | 6.1 | 5.0 | 5.9 | 7.3 | 10.3 | 10.6 | 7.0 | 10.4 | |
| – | – | – | 51.0 | 43.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | 2.0% | 2.3% | -1.9% | -2.2% | -2.7% | -4.4% | -5.4% | -6.5% | -7.0% | -11.1% | -10.1% | -23.7% | -17.4% | -26.3% | -26.9% | -22.8% | -27.5% | -23.1% | -40.2% | -41.6% | -46.9% | -45.1% | -42.3% | -41.4% | -34.7% | -18.9% | -14.1% | -16.5% | -13.9% | -17.6% | -19.3% | -20.4% | -18.9% | -14.4% | -14.1% | -18.4% | -8.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | 99.8% | 99.7% | 98.7% | 98.1% | 94.4% | 92.0% | 85.2% | -43.6% | -29.3% | -1,545.7% | -2,014.8% | -5,303.7% | -254,822.2% | -130,194.4% | -6,217.5% | 90.7% | 91.4% | 90.1% | 89.7% | 89.4% | 89.3% | 89.3% | 89.2% | 88.8% | 88.1% | 87.7% | 87.6% | 87.9% | 88.7% | 89.5% | 89.9% | 90.3% | 90.2% | 89.7% | 88.5% | 88.0% | 88.7% | 89.9% | 90.8% | |
| – | 4.6% | 4.9% | -6.7% | 12.4% | -124.9% | -182.9% | -473.5% | -4,352.0% | -3,911.8% | -5,762.3% | -7,966.1% | -10,852.4% | -608,211.1% | -697,811.1% | -35,928.2% | -3,634.9% | -1,074.2% | -592.7% | -329.7% | -250.1% | -192.1% | -162.8% | -145.6% | -126.0% | -122.8% | -116.4% | -104.5% | -92.2% | -79.2% | -82.1% | -93.7% | -93.7% | -107.1% | -117.5% | -131.1% | -138.2% | -113.7% | -77.0% | -35.3% | |
| – | -18.1% | -13.8% | -20.9% | 7.2% | -125.1% | -182.2% | -465.0% | -4,261.7% | -3,834.7% | -5,611.3% | -7,693.8% | -10,416.0% | -584,144.4% | -674,972.2% | -35,044.9% | -3,572.4% | -1,088.9% | -604.8% | -349.0% | -283.4% | -230.7% | -209.3% | -197.2% | -175.2% | -169.6% | -163.2% | -149.5% | -135.2% | -123.6% | -123.7% | -133.6% | -129.1% | -140.4% | -150.7% | -164.4% | -170.6% | -139.8% | -94.8% | -51.7% | |
| – | 19.9% | 19.2% | 12.9% | 28.6% | -61.6% | -101.7% | -239.5% | -2,316.2% | -1,920.6% | -3,094.9% | -4,580.5% | -6,426.2% | -396,344.4% | -494,972.2% | -26,536.6% | -2,918.8% | -907.7% | -513.7% | -293.8% | -217.9% | -178.3% | -151.5% | -151.2% | -136.8% | -135.0% | -130.5% | -116.8% | -110.4% | -92.6% | -97.9% | -101.3% | -107.9% | -107.4% | -116.9% | -131.1% | -143.1% | -148.2% | -118.2% | -84.3% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -421.2% | -19.4% | -12.1% | -7.2% | 3.1% | -29.2% | -24.2% | -36.8% | -59.9% | -84.0% | -34.9% | -39.2% | -42.6% | -58.3% | -80.8% | -91.4% | -113.6% | -133.3% | -152.5% | -198.1% | -358.0% | -1,317.2% | – | – | – | – | – | – | – | – | – | -374.7% | -452.2% | – | – | – | – | – | – | – | |
| -243.6% | -13.7% | – | -6.7% | 2.9% | -26.4% | -23.1% | -34.4% | -55.1% | -73.1% | -33.2% | -37.0% | -39.6% | -52.0% | -72.8% | -80.9% | -97.9% | -105.3% | -119.7% | -72.5% | -83.9% | -92.5% | -68.4% | -77.8% | -85.1% | -80.1% | -98.3% | -113.7% | -54.0% | -57.3% | -52.0% | -40.3% | -38.2% | -44.4% | -55.9% | -74.2% | -89.0% | -76.6% | -52.5% | -38.7% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | -18 | – | – | – | – | – | – | – | – | -244 | -89 | -65 | – | -25 | -35 | -23 | – | -39 | -62 | -54 | -41 | -34 | -8.7 | 44 | 43 | 62 | 79 | -20 | 3.5 | -34 | -121 | -2.4 | -47 | 19 | 31 | 34 | 11 | 80 | 112 | |
| – | -17.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 57.8% | 70.7% | – | 93.7% | 93.9% | 90.7% | 95.7% | 93.5% | 92.0% | 87.0% | 95.1% | 94.2% | 93.0% | 89.1% | 90.1% | 88.6% | 86.2% | 79.0% | 78.5% | 36.6% | 23.4% | 7.0% | -10.3% | -28.0% | -49.3% | -65.1% | -103.2% | -145.2% | -21.7% | -36.6% | -20.0% | 10.8% | 8.5% | -3.1% | -18.8% | -44.7% | -62.4% | -52.6% | -49.0% | -52.4% | |
| – | 0.2 | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.4 | – | – | – | – | – | – | – | – | – | 3.3 | 4.8 | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.91 | -0.29 | -0.22 | -0.58 | 0.18 | -1.47 | -1.96 | -2.65 | -3.85 | -4.67 | -4.33 | -4.23 | -4.30 | -4.97 | -5.74 | -5.99 | -6.21 | -5.80 | -5.24 | -4.99 | -5.04 | -4.94 | -5.01 | -5.01 | -4.80 | -4.73 | -4.77 | -4.62 | -3.23 | -2.83 | -3.13 | -3.08 | -2.68 | -2.70 | -2.92 | -3.25 | -3.43 | -3.12 | -2.65 | -1.94 | |
| 0.00 | 1.60 | 1.60 | 2.76 | 2.54 | 1.17 | 1.08 | 0.57 | 0.09 | 0.12 | 0.08 | 0.06 | 0.04 | 0.00 | 0.00 | 0.02 | 0.17 | 0.53 | 0.87 | 1.43 | 1.78 | 2.14 | 2.39 | 2.54 | 2.74 | 2.79 | 2.92 | 3.09 | 2.39 | 2.29 | 2.53 | 2.31 | 2.07 | 1.92 | 1.94 | 1.97 | 2.01 | 2.23 | 2.80 | 3.75 | |
| 0.45 | 1.49 | 1.82 | 8.05 | 5.84 | 5.03 | 8.11 | 7.19 | 6.44 | 5.56 | 12.39 | 10.79 | 10.08 | 8.52 | 7.11 | 6.56 | 5.46 | 4.35 | 3.44 | 2.52 | 1.41 | 0.38 | -0.75 | -1.80 | -2.78 | -3.84 | -5.01 | -5.90 | -1.30 | -1.80 | -1.20 | 0.82 | 0.59 | -0.19 | -0.98 | -1.96 | -2.40 | -2.14 | -2.48 | -2.63 | |
| -0.95 | 0.32 | 0.31 | 0.35 | 0.73 | -0.72 | -1.09 | -1.36 | -2.09 | -2.34 | -2.39 | -2.52 | -2.65 | -3.37 | -4.21 | -4.54 | -5.07 | -4.84 | -4.45 | -4.20 | -3.88 | -3.82 | -3.62 | -3.84 | -3.75 | -3.76 | -3.81 | -3.61 | -2.64 | -2.12 | -2.47 | -2.34 | -2.24 | -2.06 | -2.26 | -2.59 | -2.87 | -3.31 | -3.31 | -3.16 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.